v3.26.3
Segment Reporting (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2026
USD ($)
segment
Sep. 30, 2025
USD ($)
Segment Reporting [Line Items]                
Number of operating segments | segment             1  
Number of reportable segments | segment             1  
Revenue $ 1,899     $ 795     $ 4,972 $ 3,150
Less: Significant segment expenses                
Net loss (28,956) $ (33,530) $ (18,331) (15,099) $ (12,587) $ (12,433) (80,817) (40,119)
R&D                
Segment Reporting [Line Items]                
Revenue 1,899     795     4,972 3,150
Less: Significant segment expenses                
Personnel-related expenses 6,542     4,922     18,627 15,701
Clinical and preclinical expenses 5,356     4,313     15,056 13,502
Facilities-related and overhead 1,820     2,584     5,370 6,582
Professional and consulting fees 1,365     2,204     4,229 5,390
Corporate expenses 603     297     1,354 1,334
Travel and entertainment 242     126     816 420
Plus: Other segment (loss) income (14,927)     (1,448)     (40,337) (340)
Net loss $ (28,956)     $ (15,099)     $ (80,817) $ (40,119)